Dose for your Liver:
The Study

Transparency and effectiveness is at the heart of everything we do, ensuring you receive a product that truly delivers on its promises.

Study 1 Overview

Study Background

We don’t rely on promises. We rely on data. Our Dose for your Liver® formula is evaluated in a gold-standard clinical trial to ensure they perform the way they’re designed to.*

Study Attributes

3 months 108 healthy participants

The Results

The Results
85%

saw a positive impact on AST levels*†

81%

saw a positive impact on ALT levels*†

†Based on a 3-month, randomized, double-blind, placebo- controlled clinical study, when taken daily.

Study 2 Overview

Study Background

This study evaluated the impact of Dose for Your Liver® in a healthy population taking a proactive approach to liver support.
We aimed to measure how daily use influences key markers in individuals maintaining their liver health.*

Study Attributes

6 months 130 Participants

The Results

ALT Levels Alanine Aminotransferase

61%

of participants reported a positive impact on ALT levels*‡

Alanine Aminotransferase (ALT)

61%

saw positive impact on ALT levels at 6 months in our clinical study*‡

ALT (Alanine Aminotransferase) is an enzyme primarily found in the liver. It's measured to assess liver function.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

‡Based on a 6-month, randomized, double-blind, placebo-controlled clinical study, when taken twice daily.